<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=undefined&type=result"></script>');
-->
</script>

COPY SCRIPT

For further information contact us at helpdesk@openaire.eu

Antineoplastic agents and thrombotic microangiopathy

descriptionPublicationkeyboard_double_arrow_right Article 23 Jun 2016Publisher:SAGE PublicationsJournal:Journal of Oncology Pharmacy Practice, volume 23, pages 135-142 (issn: 1078-1552, eissn: 1477-092X,

Authors: Jean Paul Atallah; Gwenalyn Garcia;

doi: 10.1177/1078155216628324

pmid: 26854265

Antineoplastic agents and thrombotic microangiopathy

- Summary
- Subjects
- Metrics

Abstract

Thrombotic microangiopathy is an uncommon but reported adverse effect of a variety of antineoplastic drugs, including chemotherapy agents such as mitomycin C and gemcitabine, and newer targeted agents such as the vascular endothelial growth factor inhibitors. We present a review of thrombotic microangiopathy associated with antineoplastic agents and its implications in current cancer therapy.

Related Organizations

Staten Island University Hospital
United States

Keywords

Vascular Endothelial Growth Factor A, Thrombotic Microangiopathies, Incidence, Mitomycin, Interferon-alpha, Antineoplastic Agents, Deoxycytidine, Gemcitabine, Neoplasms, Antineoplastic Combined Chemotherapy Protocols, Humans, Immunologic Factors, Molecular Targeted Therapy, Proteasome Inhibitors, Signal Transduction

Impact byBIP!

	citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	24
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 10%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%